Research Progress on Podocyte Pyroptosis in Diabetic Nephropathy

被引:0
|
作者
Zhu, Rong [1 ]
Bai, Xue [1 ]
Xu, Chengyi [1 ]
Qi, Wenyi [1 ]
Luo, Ping [1 ]
Wu, Man [1 ]
Luo, Manyu [1 ]
机构
[1] Second Hosp Jilin Univ, Dept Nephrol & Rheumatol, Changchun 130041, Jilin, Peoples R China
关键词
Diabetic nephropathy; podocyte; pyroptosis; inflammasome; pathogenesis; signal pathways; drugs; THIOREDOXIN-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; LONG NONCODING RNAS; INFLAMMASOME ACTIVATION; OXIDATIVE STRESS; NLRP3; INFLAMMASOME; GASDERMIN D; CELL-DEATH; INJURY;
D O I
10.2174/0109298673304627240525135453
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pyroptosis is a recently discovered type of lytic-programmed cell necrosis. The process involves cells assembling an inflammasome and cleaving gasdermin (GSDM) to trigger the release of pro-inflammatory cytokines that eventually induce inflammatory cell death. Diabetic nephropathy (DN) is a microvascular complication of diabetes mellitus, which leads to end-stage renal disease. Podocyte damage or loss is an important feature of diabetic kidney injury. Pyroptosis involvement in podocyte injury is closely associated with DN progression, manifesting as increased renal fibrosis, glomerulosclerosis, and tubular injury. The study aims to elucidate the mechanism of pyroptosis and summarize the pathways and potential inhibitors related to pyroptosis activation in DN podocytes. We undertook a search of bibliographic databases for peer-reviewed research literature on various aspects of pyroptosis. Multiple different pathways mediate podocyte pyroptosis to promote DN progression. Inhibition of pyroptosis can reduce podocyte damage and improve renal function in DN, suggesting that pyroptosis may help identify potential new therapeutic targets for DN treatment.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy
    Dai, Haoran
    Liu, Qingquan
    Liu, Baoli
    [J]. JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [2] Research into the glomerular podocyte - is it relevant to diabetic nephropathy?
    White, K. E.
    [J]. DIABETIC MEDICINE, 2006, 23 (07) : 715 - 719
  • [3] Pyroptosis in diabetic nephropathy
    Al Mamun, Abdullah
    Mimi, Anjuman Ara
    Wu, Yanqing
    Zaeem, Muhammad
    Aziz, Md. Abdul
    Suchi, Suzia Aktar
    Alyafeai, Eman
    Munir, Fahad
    Xiao, Jian
    [J]. CLINICA CHIMICA ACTA, 2021, 523 : 131 - 143
  • [4] Research Progress of Pyroptosis in Diabetic Kidney Disease
    Fan, Qingqing
    Li, Rongxuan
    Wei, Huiting
    Xue, Weiyue
    Li, Xiang
    Xia, Ziyao
    Zhao, Le
    Qiu, Ye
    Cui, Di
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [5] Podocyte biology in diabetic nephropathy
    Li, J. J.
    Kwak, S. J.
    Jung, D. S.
    Kim, J-J
    Yoo, T-H
    Ryu, D-R
    Han, S. H.
    Choi, H. Y.
    Lee, J. E.
    Moon, S. J.
    Kim, D. K.
    Han, D. S.
    Kang, S-W
    [J]. KIDNEY INTERNATIONAL, 2007, 72 : S36 - S42
  • [6] Podocyte hypertrophy in diabetic nephropathy
    Kim, NH
    [J]. NEPHROLOGY, 2005, 10 : S14 - S16
  • [7] Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis
    Zhu, Wei
    Li, Yuan-Yuan
    Zeng, Han-Xu
    Liu, Xue-Qi
    Sun, Yu-Ting
    Jiang, Ling
    Xia, Ling-Ling
    Wu, Yong-Gui
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [8] Pyroptosis in diabetes and diabetic nephropathy
    Cao, Zhaohui
    Huang, Di
    Tang, Cifei
    Lu, Yang
    Huang, Shuangxiang
    Peng, Cuiying
    Hu, Xiaobo
    [J]. CLINICA CHIMICA ACTA, 2022, 531 : 188 - 196
  • [9] Research progress in signalling pathway in diabetic nephropathy
    Ni, Wei-Jian
    Tang, Li-Qin
    Wei, Wei
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 (03) : 221 - 233
  • [10] MicroRNAs in Podocyte Injury in Diabetic Nephropathy
    Ishii, Hiroki
    Kaneko, Shohei
    Yanai, Katsunori
    Aomatsu, Akinori
    Hirai, Keiji
    Ookawara, Susumu
    Ishibashi, Kenichi
    Morishita, Yoshiyuki
    [J]. FRONTIERS IN GENETICS, 2020, 11